InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by ARCH Venture Fund XIII, L.P.. Insider active across 1 company, notably Lyell Immunopharma, Inc.. Cumulatively, 1 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €10.8m. History available since 6 March 2026. The latest transaction was filed on 6 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration